Industry Insights

Trastuzumab Then and Now: A look at …

Trastuzumab was the first approved monoclonal antibody to target the oncogene HER2 protein... Trastuzumab was the first approved monoclonal antibody to target the oncogene HER2 protein, and its development was a life-changing therapy for women with HER2+ breast cancer. The significance of the role trastuzumab has played in treatment of breast cancer was recognized in [...]